-
1
-
-
84957852098
-
Les acides nucléiques du plasma sanguin chez l'homme (Nucleic acids in human blood plasma)
-
Mandel P, Métais P. Les acides nucléiques du plasma sanguin chez l'homme (Nucleic acids in human blood plasma). C R Acad Sci Paris. 1948;142:241-3.
-
(1948)
C R Acad Sci Paris
, vol.142
, pp. 241-243
-
-
Mandel, P.1
Métais, P.2
-
2
-
-
0017360626
-
Free DNA in the serum of cancer patients and the effect of therapy
-
Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646-50.
-
(1977)
Cancer Res
, vol.37
, pp. 646-650
-
-
Leon, S.A.1
Shapiro, B.2
Sklaroff, D.M.3
Yaros, M.J.4
-
3
-
-
0033168068
-
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations
-
Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, et al. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res. 1999;59:3251-6.
-
(1999)
Cancer Res
, vol.59
, pp. 3251-3256
-
-
Silva, J.M.1
Dominguez, G.2
Garcia, J.M.3
Gonzalez, R.4
Villanueva, M.J.5
Navarro, F.6
-
4
-
-
0033026117
-
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
-
Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, et al. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer. 1999;80:1262-4.
-
(1999)
Br J Cancer
, vol.80
, pp. 1262-1264
-
-
Silva, J.M.1
Dominguez, G.2
Villanueva, M.J.3
Gonzalez, R.4
Garcia, J.M.5
Corbacho, C.6
-
5
-
-
0032902278
-
TP53 gene mutations in plasma DNA of cancer patients
-
Silva JM, Gonzalez R, Dominguez G, Garcia JM, Espana P, Bonilla F. TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosomes Cancer. 1999;24:160-1.
-
(1999)
Genes Chromosomes Cancer
, vol.24
, pp. 160-161
-
-
Silva, J.M.1
Gonzalez, R.2
Dominguez, G.3
Garcia, J.M.4
Espana, P.5
Bonilla, F.6
-
6
-
-
84901842265
-
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
-
Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24:766-9.
-
(2014)
Cell Res
, vol.24
, pp. 766-769
-
-
Thakur, B.K.1
Zhang, H.2
Becker, A.3
Matei, I.4
Huang, Y.5
Costa-Silva, B.6
-
7
-
-
0034750559
-
About the possible origin and mechanism of circulating DNA apoptosis and active DNA release
-
Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313:139-42.
-
(2001)
Clin Chim Acta
, vol.313
, pp. 139-142
-
-
Stroun, M.1
Lyautey, J.2
Lederrey, C.3
Olson-Sand, A.4
Anker, P.5
-
8
-
-
0026674790
-
Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance
-
Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol. 1992;90:56-62.
-
(1992)
Clin Exp Immunol
, vol.90
, pp. 56-62
-
-
Rumore, P.1
Muralidhar, B.2
Lin, M.3
Lai, C.4
Steinman, C.R.5
-
9
-
-
79957458567
-
Cell-free nucleic acids as biomarkers in cancer patients
-
Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426-37.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 426-437
-
-
Schwarzenbach, H.1
Hoon, D.S.2
Pantel, K.3
-
10
-
-
0035866393
-
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells
-
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659-65.
-
(2001)
Cancer Res
, vol.61
, pp. 1659-1665
-
-
Jahr, S.1
Hentze, H.2
Englisch, S.3
Hardt, D.4
Fackelmayer, F.O.5
Hesch, R.D.6
-
11
-
-
33749579082
-
Isolation and comparative study of cell-free nucleic acids from human urine
-
Bryzgunova OE, Skvortsova TE, Kolesnikova EV, Starikov AV, Rykova EY, Vlassov VV, et al. Isolation and comparative study of cell-free nucleic acids from human urine. Ann N Y Acad Sci. 2006;1075:334-40.
-
(2006)
Ann N Y Acad Sci
, vol.1075
, pp. 334-340
-
-
Bryzgunova, O.E.1
Skvortsova, T.E.2
Kolesnikova, E.V.3
Starikov, A.V.4
Rykova, E.Y.5
Vlassov, V.V.6
-
12
-
-
71049146803
-
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
-
Kohler C, Radpour R, Barekati Z, Asadollahi R, Bitzer J, Wight E, et al. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer. 2009;8:105.
-
(2009)
Mol Cancer
, vol.8
, pp. 105
-
-
Kohler, C.1
Radpour, R.2
Barekati, Z.3
Asadollahi, R.4
Bitzer, J.5
Wight, E.6
-
13
-
-
78650878367
-
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
-
Roth C, Pantel K, Muller V, Rack B, Kasimir-Bauer S, Janni W, et al. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression. BMC Cancer. 2011;11:4.
-
(2011)
BMC Cancer
, vol.11
, pp. 4
-
-
Roth, C.1
Pantel, K.2
Muller, V.3
Rack, B.4
Kasimir-Bauer, S.5
Janni, W.6
-
14
-
-
84878965534
-
Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin
-
Stoetzer OJ, Fersching DM, Salat C, Steinkohl O, Gabka CJ, Hamann U, et al. Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin. Cancer Lett. 2013;336:140-8.
-
(2013)
Cancer Lett
, vol.336
, pp. 140-148
-
-
Stoetzer, O.J.1
Fersching, D.M.2
Salat, C.3
Steinkohl, O.4
Gabka, C.J.5
Hamann, U.6
-
16
-
-
84871630944
-
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
-
Benesova L, Belsanova B, Suchanek S, Kopeckova M, Minarikova P, Lipska L, et al. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Anal Biochem. 2013;433:227-34.
-
(2013)
Anal Biochem
, vol.433
, pp. 227-234
-
-
Benesova, L.1
Belsanova, B.2
Suchanek, S.3
Kopeckova, M.4
Minarikova, P.5
Lipska, L.6
-
17
-
-
84905814375
-
DNA methylation markers for early detection of women's cancer: promise and challenges
-
Wittenberger T, Sleigh S, Reisel D, Zikan M, Wahl B, Alunni-Fabbroni M, et al. DNA methylation markers for early detection of women's cancer: promise and challenges. Epigenomics. 2014;6:311-27.
-
(2014)
Epigenomics
, vol.6
, pp. 311-327
-
-
Wittenberger, T.1
Sleigh, S.2
Reisel, D.3
Zikan, M.4
Wahl, B.5
Alunni-Fabbroni, M.6
-
18
-
-
84887612347
-
Circulating nucleic acids as biomarkers in breast cancer
-
Schwarzenbach H. Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res. 2013;15:211.
-
(2013)
Breast Cancer Res
, vol.15
, pp. 211
-
-
Schwarzenbach, H.1
-
20
-
-
33749260689
-
Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients
-
Huang ZH, Li LH, Hua D. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett. 2006;243:64-70.
-
(2006)
Cancer Lett
, vol.243
, pp. 64-70
-
-
Huang, Z.H.1
Li, L.H.2
Hua, D.3
-
21
-
-
80052736273
-
Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
-
Schwarzenbach H, Muller V, Milde-Langosch K, Steinbach B, Pantel K. Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease. Mol Biosyst. 2011;7:2848-54.
-
(2011)
Mol Biosyst
, vol.7
, pp. 2848-2854
-
-
Schwarzenbach, H.1
Muller, V.2
Milde-Langosch, K.3
Steinbach, B.4
Pantel, K.5
-
22
-
-
84856435964
-
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
-
Payne RE, Hava NL, Page K, Blighe K, Ward B, Slade M, et al. The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. Br J Cancer. 2012;106:375-82.
-
(2012)
Br J Cancer
, vol.106
, pp. 375-382
-
-
Payne, R.E.1
Hava, N.L.2
Page, K.3
Blighe, K.4
Ward, B.5
Slade, M.6
-
23
-
-
33748924308
-
Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics
-
Klein CA, Holzel D. Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle. 2006;5:1788-98.
-
(2006)
Cell Cycle
, vol.5
, pp. 1788-1798
-
-
Klein, C.A.1
Holzel, D.2
-
24
-
-
33749008215
-
Prediction of breast tumor progression by integrity of free circulating DNA in serum
-
Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006;24:4270-6.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4270-4276
-
-
Umetani, N.1
Giuliano, A.E.2
Hiramatsu, S.H.3
Amersi, F.4
Nakagawa, T.5
Martino, S.6
Hoon, D.S.7
-
25
-
-
84899069346
-
Diagnostic relevance of plasma DNA and DNA integrity for breast cancer
-
Stotzer OJ, Lehner J, Fersching-Gierlich D, Nagel D, Holdenrieder S. Diagnostic relevance of plasma DNA and DNA integrity for breast cancer. Tumour Biol. 2014;35:1183-91.
-
(2014)
Tumour Biol
, vol.35
, pp. 1183-1191
-
-
Stotzer, O.J.1
Lehner, J.2
Fersching-Gierlich, D.3
Nagel, D.4
Holdenrieder, S.5
-
26
-
-
84903692972
-
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
-
Madhavan D, Wallwiener M, Bents K, Zucknick M, Nees J, Schott S, et al. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat. 2014;146:163-74.
-
(2014)
Breast Cancer Res Treat
, vol.146
, pp. 163-174
-
-
Madhavan, D.1
Wallwiener, M.2
Bents, K.3
Zucknick, M.4
Nees, J.5
Schott, S.6
-
27
-
-
84883590118
-
Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy
-
Lehner J, Stotzer OJ, Fersching D, Nagel D, Holdenrieder S. Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy. Clin Chim Acta. 2013;425:206-11.
-
(2013)
Clin Chim Acta
, vol.425
, pp. 206-211
-
-
Lehner, J.1
Stotzer, O.J.2
Fersching, D.3
Nagel, D.4
Holdenrieder, S.5
-
28
-
-
84898542288
-
Liquid biopsies: genotyping circulating tumor DNA
-
Diaz Jr LA, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579-86.
-
(2014)
J Clin Oncol
, vol.32
, pp. 579-586
-
-
Diaz, L.A.1
Bardelli, A.2
-
29
-
-
84879493428
-
Noninvasive detection of HER2 amplification with plasma DNA digital PCR
-
Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, et al. Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clin Cancer Res. 2013;19:3276-84.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3276-3284
-
-
Gevensleben, H.1
Garcia-Murillas, I.2
Graeser, M.K.3
Schiavon, G.4
Osin, P.5
Parton, M.6
-
31
-
-
84863011201
-
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
-
Shaw JA, Page K, Blighe K, Hava N, Guttery D, Ward B, et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 2012;22:220-31.
-
(2012)
Genome Res
, vol.22
, pp. 220-231
-
-
Shaw, J.A.1
Page, K.2
Blighe, K.3
Hava, N.4
Guttery, D.5
Ward, B.6
-
32
-
-
84928186818
-
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
-
283ra251
-
Bosch A, Li Z, Bergamaschi A, Ellis H, Toska E, Prat A, et al. PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer. Sci Transl Med. 2015;7:283ra251.
-
(2015)
Sci Transl Med
, vol.7
-
-
Bosch, A.1
Li, Z.2
Bergamaschi, A.3
Ellis, H.4
Toska, E.5
Prat, A.6
-
33
-
-
84925460062
-
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
-
Oshiro C, Kagara N, Naoi Y, Shimoda M, Shimomura A, Maruyama N, et al. PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients. Breast Cancer Res Treat. 2015;150:299-307.
-
(2015)
Breast Cancer Res Treat
, vol.150
, pp. 299-307
-
-
Oshiro, C.1
Kagara, N.2
Naoi, Y.3
Shimoda, M.4
Shimomura, A.5
Maruyama, N.6
-
34
-
-
84921758615
-
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
-
Rothe F, Laes JF, Lambrechts D, Smeets D, Vincent D, Maetens M, et al. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer. Ann Oncol. 2014;25:1959-65.
-
(2014)
Ann Oncol
, vol.25
, pp. 1959-1965
-
-
Rothe, F.1
Laes, J.F.2
Lambrechts, D.3
Smeets, D.4
Vincent, D.5
Maetens, M.6
-
35
-
-
84896371874
-
Detection of circulating tumor DNA in early- and late-stage human malignancies
-
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra224.
-
(2014)
Sci Transl Med
, vol.6
, pp. 224ra224
-
-
Bettegowda, C.1
Sausen, M.2
Leary, R.J.3
Kinde, I.4
Wang, Y.5
Agrawal, N.6
-
36
-
-
84875520648
-
Analysis of circulating tumor DNA to monitor metastatic breast cancer
-
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368:1199-209.
-
(2013)
N Engl J Med
, vol.368
, pp. 1199-1209
-
-
Dawson, S.J.1
Tsui, D.W.2
Murtaza, M.3
Biggs, H.4
Rueda, O.M.5
Chin, S.F.6
-
37
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013;497:108-12.
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
Gale, D.4
Forshew, T.5
Piskorz, A.M.6
-
38
-
-
84906827268
-
The dynamic range of circulating tumor DNA in metastatic breast cancer
-
Heidary M, Auer M, Ulz P, Heitzer E, Petru E, Gasch C, et al. The dynamic range of circulating tumor DNA in metastatic breast cancer. Breast Cancer Res. 2014;16:421.
-
(2014)
Breast Cancer Res
, vol.16
, pp. 421
-
-
Heidary, M.1
Auer, M.2
Ulz, P.3
Heitzer, E.4
Petru, E.5
Gasch, C.6
-
39
-
-
82455218972
-
Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
-
Gobel G, Auer D, Gaugg I, Schneitter A, Lesche R, Muller-Holzner E, et al. Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. Breast Cancer Res Treat. 2011;130:109-17.
-
(2011)
Breast Cancer Res Treat
, vol.130
, pp. 109-117
-
-
Gobel, G.1
Auer, D.2
Gaugg, I.3
Schneitter, A.4
Lesche, R.5
Muller-Holzner, E.6
-
40
-
-
84857911910
-
Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
-
Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, et al. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay. Breast Cancer Res Treat. 2012;132:165-73.
-
(2012)
Breast Cancer Res Treat
, vol.132
, pp. 165-173
-
-
Yamamoto, N.1
Nakayama, T.2
Kajita, M.3
Miyake, T.4
Iwamoto, T.5
Kim, S.J.6
-
41
-
-
84865853256
-
Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR Is predictive of poor prognosis for breast cancer patients
-
Fujita N, Nakayama T, Yamamoto N, Kim SJ, Shimazu K, Shimomura A, et al. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR Is predictive of poor prognosis for breast cancer patients. Oncology. 2012;83:273-82.
-
(2012)
Oncology
, vol.83
, pp. 273-282
-
-
Fujita, N.1
Nakayama, T.2
Yamamoto, N.3
Kim, S.J.4
Shimazu, K.5
Shimomura, A.6
-
42
-
-
64949112189
-
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
-
Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, et al. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer. 2009;100:1277-86.
-
(2009)
Br J Cancer
, vol.100
, pp. 1277-1286
-
-
Auwera, I.1
Elst, H.J.2
Laere, S.J.3
Maes, H.4
Huget, P.5
Dam, P.6
-
43
-
-
13944250245
-
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
-
Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 2005;65:1141-5.
-
(2005)
Cancer Res
, vol.65
, pp. 1141-1145
-
-
Fiegl, H.1
Millinger, S.2
Mueller-Holzner, E.3
Marth, C.4
Ensinger, C.5
Berger, A.6
-
44
-
-
84864423461
-
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
-
Avraham A, Uhlmann R, Shperber A, Birnbaum M, Sandbank J, Sella A, et al. Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer. 2012;131:E1166-72.
-
(2012)
Int J Cancer
, vol.131
, pp. E1166-E1172
-
-
Avraham, A.1
Uhlmann, R.2
Shperber, A.3
Birnbaum, M.4
Sandbank, J.5
Sella, A.6
-
45
-
-
84893186983
-
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
-
Martinez-Galan J, Torres-Torres B, Nunez MI, Lopez-Penalver J, Del Moral R, Ruiz De Almodovar JM, et al. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC Cancer. 2014;14:59.
-
(2014)
BMC Cancer
, vol.14
, pp. 59
-
-
Martinez-Galan, J.1
Torres-Torres, B.2
Nunez, M.I.3
Lopez-Penalver, J.4
Moral, R.5
Ruiz De Almodovar, J.M.6
-
46
-
-
84907985819
-
Estrogen receptor alpha (ERalpha) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients
-
Hagrass HA, Pasha HF, Ali AM. Estrogen receptor alpha (ERalpha) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients. Gene. 2014;552:81-6.
-
(2014)
Gene
, vol.552
, pp. 81-86
-
-
Hagrass, H.A.1
Pasha, H.F.2
Ali, A.M.3
-
47
-
-
84929674483
-
Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer
-
Fu D, Ren C, Tan H, Wei J, Zhu Y, He C, et al. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer. Medicine (Baltimore). 2015;94:e637.
-
(2015)
Medicine (Baltimore)
, vol.94
, pp. e637
-
-
Fu, D.1
Ren, C.2
Tan, H.3
Wei, J.4
Zhu, Y.5
He, C.6
-
48
-
-
84872031717
-
SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer
-
Chimonidou M, Strati A, Malamos N, Georgoulias V, Lianidou ES. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer. Clin Chem. 2012;59:270-9.
-
(2012)
Clin Chem
, vol.59
, pp. 270-279
-
-
Chimonidou, M.1
Strati, A.2
Malamos, N.3
Georgoulias, V.4
Lianidou, E.S.5
-
49
-
-
84867988577
-
Maspin: molecular mechanisms and therapeutic implications
-
Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, Hendrix MJ. Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 2012;31:529-51.
-
(2012)
Cancer Metastasis Rev
, vol.31
, pp. 529-551
-
-
Bodenstine, T.M.1
Seftor, R.E.2
Khalkhali-Ellis, Z.3
Seftor, E.A.4
Pemberton, P.A.5
Hendrix, M.J.6
-
50
-
-
78751569876
-
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression
-
Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, et al. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol. 2011;32:23-32.
-
(2011)
Tumour Biol
, vol.32
, pp. 23-32
-
-
Sharma, G.1
Mirza, S.2
Parshad, R.3
Srivastava, A.4
Gupta, S.D.5
Pandya, P.6
-
51
-
-
84903196176
-
Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity
-
Guerrero-Preston R, Hadar T, Ostrow KL, Soudry E, Echenique M, Ili-Gangas C, et al. Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep. 2014;32:505-12.
-
(2014)
Oncol Rep
, vol.32
, pp. 505-512
-
-
Guerrero-Preston, R.1
Hadar, T.2
Ostrow, K.L.3
Soudry, E.4
Echenique, M.5
Ili-Gangas, C.6
-
52
-
-
84868368069
-
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls
-
Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF. Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics. 2012;7:1258-67.
-
(2012)
Epigenetics
, vol.7
, pp. 1258-1267
-
-
Sturgeon, S.R.1
Balasubramanian, R.2
Schairer, C.3
Muss, H.B.4
Ziegler, R.G.5
Arcaro, K.F.6
|